title: Increasing HPV vaccination through policy for public health benefit.
abstract: Vaccines against specific types of human papillomavirus (HPV) linked to cancer and other diseases have been met with mixed acceptance globally and in the United States. Policy-level interventions have been shown to be effective in increasing public health benefit. Government policies and mandates may result in improved HPV vaccination coverage and reduced disease burden, and alternative policies that improve unhindered access to HPV vaccination may allow success as well. The purpose of this commentary is to summarize policy efforts to maximize the public health benefit of HPV vaccination. We examine selected examples of HPV vaccination policy in global contexts and in the United States.
authors.affiliation: a Arnold School of Public Health, University of South Carolina , Columbia , SC , USA.
authors.forename: Heather M
authors.initials: HM
authors.lastname: Brandt
authors.affiliation: b Medical University of South Carolina , Charleston , SC , USA.
authors.forename: Jennifer Young
authors.initials: JY
authors.lastname: Pierce
authors.affiliation: c South Carolina Coalition for Healthy Families , Columbia , SC , USA.
authors.forename: Ashley
authors.initials: A
authors.lastname: Crary
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006291:Health Policy; D006801:Humans; D016134:Organizational Policy; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D011634:Public Health; D014481:United States; D014611:Vaccination / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines
keywords: HPV; HPV vaccination; cancer prevention; public health intervention; public health policy; vaccination